| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/08/2008 | US20080107653 Heat resistant, chimeric verotoxin subunits for use in developing vaccine for prevention and treatment of microorganismal infection |
| 05/08/2008 | US20080107652 Using transgenic, probiotic microorgansims as therapeutic vechicles for prevention and treatment of infection in shrimp |
| 05/08/2008 | US20080107651 Using immunoglobulin specific to shiga-like toxin as therapeutic tool in treatment and prevention of enterohemorrhagic escherichia infection |
| 05/08/2008 | US20080107650 Administering (S,S)-2-[1-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl]-ethylamino]-4-methylpentanoic acid for treatment of inflammatory bowel disease, Crohn's disease; corticosteroid free therapy |
| 05/08/2008 | US20080107649 Virosomes as adjuvants; cyclization; screening antibodies |
| 05/08/2008 | US20080107648 Immunoglobulin specific to delta-like ligand 4 (DII4) for use in prevention and treatment of cell proliferative disorders |
| 05/08/2008 | US20080107647 Methods and Compositions Relating to Ccr5 Antagonist, Inf-Y and Il-13 Induced Inflammation |
| 05/08/2008 | US20080107646 Administering phenylbutyric acid derivative and pharmaceutically acceptable carrier |
| 05/08/2008 | US20080107645 Antibody raised against a parasitic protozoan isolate; diagnostic assays for the detection of parasites in animals |
| 05/08/2008 | US20080107644 Pai-1 binding modulators for the treatment of ocular disorders |
| 05/08/2008 | US20080107643 Transmembrane polypeptide for use in identifying modulators for prevention and treatment of cell proliferative, fibrotic and sclerotic disorders |
| 05/08/2008 | US20080107642 Antibodies against gpr64 and uses thereof |
| 05/08/2008 | US20080107641 Treating ischemic events in humans via administration of tissue plasminogen activator; antiischemic agents |
| 05/08/2008 | US20080107630 Human matrix metalloproteinase-8 gene delivery enhances the oncolytic activity of a replicating adenovirus |
| 05/08/2008 | US20080107627 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 05/08/2008 | US20080107622 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies |
| 05/08/2008 | US20080107620 Human Cytomegalovirus Immunotherapy |
| 05/08/2008 | US20080107618 Use of fullerenes for the treatment of mast cell and basophil-mediated disease |
| 05/08/2008 | US20080107603 Administering L-ergothioneine; Alzheimer's disease, multiple sclerosis, stroke, traumatic brain injury, spinal cord injuries |
| 05/08/2008 | US20080107602 Neospora caninum isolate |
| 05/08/2008 | US20080107601 Nanobodies Tm Against Amyloid-Beta and Polypeptides Comprising the Same for the Treatment of Degenerative Neural Diseases Such as Alzheimer's Disease |
| 05/08/2008 | US20080107597 Isolation of antibodies that cross-react and neutralize rankl originating from multiple species |
| 05/08/2008 | US20080107596 Breast cancer specific genes; a polynucleotide, a protein expressed by a polynucleotide, a polynucleotide capable of hybridizing under stringent conditions |
| 05/08/2008 | US20080107595 Anti-CCR5 antibody |
| 05/08/2008 | DE102006051516A1 (Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins (Base-) modified RNA to increase in expression of a protein |
| 05/08/2008 | CA2668295A1 Fgfr4 antibodies |
| 05/08/2008 | CA2668284A1 Proteins for use in diagnosing and treating infection and disease |
| 05/08/2008 | CA2668027A1 Fgfr4 promotes cancer cell resistance in response to chemotherapeutic drugs |
| 05/08/2008 | CA2667970A1 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type ii receptor (amhr-ii) |
| 05/08/2008 | CA2667706A1 Compositions and methods for treating ocular diseases and conditions |
| 05/08/2008 | CA2667255A1 Poultry vaccine, for necrotic enteritis, comprising a mutated clostridium perfringens alpha toxin antigen, and methods of producing the vaccine |
| 05/08/2008 | CA2664343A1 High affinity human antibodies to human il-4 receptor |
| 05/08/2008 | CA2663537A1 Il-17 receptor a antigen binding proteins |
| 05/08/2008 | CA2657849A1 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions |
| 05/08/2008 | CA2651775A1 Compositions and methods for treating anthrax lethality |
| 05/08/2008 | CA2634783A1 Anti-hyperproliferative therapies targeting hdgf |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918376A1 FGFR4 promotes cancer cell resistance in response to chemotherapeutic drugs |
| 05/07/2008 | EP1918305A1 New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy |
| 05/07/2008 | EP1918304A1 Monoclonal antibodies against the human anti-müllerian hormone type II receptor (AMHR-II) |
| 05/07/2008 | EP1918303A2 method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment |
| 05/07/2008 | EP1918300A2 Peptide-based immunization therapy for treatment of atherosclerosis |
| 05/07/2008 | EP1918298A2 Peptide |
| 05/07/2008 | EP1917977A1 Therapeutic drug for heart disease and virus disease |
| 05/07/2008 | EP1917976A1 Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration |
| 05/07/2008 | EP1917975A1 Novel proteins in Enteroaggregative Escherichia Coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 05/07/2008 | EP1917974A1 Equine system for non-surgical artifical insemination |
| 05/07/2008 | EP1917972A1 Agent for ameliorating heavy metal-induced disorders, and medicinal composition, food and cosmetic containing the same |
| 05/07/2008 | EP1917970A2 Hla binding peptides and their uses |
| 05/07/2008 | EP1917040A2 Polyvalent vaccine |
| 05/07/2008 | EP1917034A1 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 05/07/2008 | EP1917033A2 Virus-like particles as vaccines for paramyxovirus |
| 05/07/2008 | EP1917032A1 Use of a botulinum toxin to improve gastric emptying and/or to treat gerd |
| 05/07/2008 | EP1917031A1 Lawsonia vaccine and methods of use thereof |
| 05/07/2008 | EP1917030A2 Immunoconjugate formulations |
| 05/07/2008 | EP1917029A2 A method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response |
| 05/07/2008 | EP1917019A2 Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection |
| 05/07/2008 | EP1917011A1 Combinations comprising dmxaa for the treatment of cancer |
| 05/07/2008 | EP1916997A2 Stable aqueous protein or antibody pharmaceutical formulations and their preparation |
| 05/07/2008 | EP1916995A1 Ph-controlled pulsatile delivery system, methods for preparation and use thereof |
| 05/07/2008 | EP1592446B1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 05/07/2008 | EP1545602B1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 05/07/2008 | EP1519755B1 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
| 05/07/2008 | EP1467757B1 Use of antibodies against the muc18 antigen |
| 05/07/2008 | EP1456651B1 Self-assembly molecules |
| 05/07/2008 | EP1385531B1 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 05/07/2008 | EP1380593B1 Soluble rage protein |
| 05/07/2008 | EP1364026B1 Human g protein-coupled receptor |
| 05/07/2008 | EP1360208B1 Method for the production of cytotoxic anti-cancer antibodies |
| 05/07/2008 | EP1141306B1 Streptococcus antigens |
| 05/07/2008 | EP1126028B1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 05/07/2008 | EP1059929B1 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 05/07/2008 | EP0991758B1 Smad6 and uses thereof |
| 05/07/2008 | EP0986636B1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
| 05/07/2008 | EP0957933B1 Vaccine composition against malaria |
| 05/07/2008 | EP0810876B1 Influenza virus subunit conjugates |
| 05/07/2008 | EP0764213B1 Vectors encoding recombinant aav genomes |
| 05/07/2008 | CN101175856A Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy |
| 05/07/2008 | CN101175509A Immunogenic compositions comprising lawsonia intracellularis |
| 05/07/2008 | CN101175508A Immunogenic compositions of staphylococcus epidermidis polypeptide antigens |
| 05/07/2008 | CN101175507A Use of rip in treating staphylococcus aureus infections |
| 05/07/2008 | CN101175495A Combination therapy |
| 05/07/2008 | CN101173295A Compositions and methods for identifying antigens which elicit an immune response |
| 05/07/2008 | CN101173285A Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 05/07/2008 | CN101172998A BASB111 polypeptide and polynucleotide from |
| 05/07/2008 | CN101172158A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 05/07/2008 | CN101172157A Vibrio parahaemolyticus tunica externa protein ompK subunit vaccine and preparation method thereof |
| 05/07/2008 | CN101172100A Stable isotonic lyophilized protein formulation |
| 05/07/2008 | CN101172099A Stable isotonic lyophilized protein formulation |
| 05/07/2008 | CN100386430C P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 05/07/2008 | CN100386343C SARS virus S protein and N protein fusion protein, and preparation and use thereof |
| 05/06/2008 | US7368565 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| 05/06/2008 | US7368557 Comprises DNA from RNA virus which codes for RNA polymerase and nonstructural protein in bacterial artificial chromosome; virions; gene therapy |
| 05/06/2008 | US7368556 Not pilC or gene involved in biosynthesis of polysaccharide capsule, IgA protease, pilin, protein which binds transferrin orlactoferrin; involved in colonization of nasopharynx or invasion of submucousal space; diagnosis and prevention of meningitis |
| 05/06/2008 | US7368545 PCA3 messenger RNA species in benign and malignant prostate tissues |
| 05/06/2008 | US7368543 Diagnosis and treatment of hepatic disorders |
| 05/06/2008 | US7368542 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions |
| 05/06/2008 | US7368537 Administering respiratory syncytial virus G protein immunogen or fragment |
| 05/06/2008 | US7368533 Recombinant polynucleotide comprising a nucleotide sequence encoding a polypeptide epitope of amino acid sequence, wherein the epitope specifically binds to anitbodies from subjects diagnosed with endometriosis |
| 05/06/2008 | US7368530 Human intestinal Npt2B |